Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bas J Wouters

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
The Journal of Molecular Diagnostics : JMD|May 20, 2017
Minimal Residual Disease Monitoring of Acute Myeloid Leukemia by Massively Multiplex Digital PCR in Patients with NPM1 MutationsNuria Mencia-Trinchant, Yang Hu, Maria Antonina Alas, et al.
Cancer Cell|November 14, 2006
Tribbles homolog 2 inactivates C/EBPalpha and causes acute myelogenous leukemiaKaren Keeshan, Yiping He, Bas J Wouters, et al.
Blood|April 8, 2021
Allele-specific expression of GATA2 due to epigenetic dysregulation in CEBPA double-mutant AMLRoger Mulet-Lazaro, Stanley van Herk, Claudia Erpelinck, et al.
Blood|January 27, 2009
Genome-wide epigenetic analysis delineates a biologically distinct immature acute leukemia with myeloid/T-lymphoid featuresMaria E Figueroa, Bas J Wouters, Lucy Skrabanek, et al.
Nature Communications|September 29, 2021
The leukemic oncogene EVI1 hijacks a MYC super-enhancer by CTCF-facilitated loopsSophie Ottema, Roger Mulet-Lazaro, Claudia Erpelinck-Verschueren, et al.
Blood|September 10, 2020
BCL6 maintains survival and self-renewal of primary human acute myeloid leukemia cellsKimihito C Kawabata, Hongliang Zong, Cem Meydan, et al.
Blood|October 8, 2025
MECOM is a master repressor of myeloid differentiation through dose control of CEBPA in acute myeloid leukemiaDorien Pastoors, Marije Havermans, Roger Mulet-Lazaro, et al.
Blood|December 24, 2010
Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entityErdogan Taskesen, Lars Bullinger, Andrea Corbacioglu, et al.
Blood|August 3, 2007
Distinct gene expression profiles of acute myeloid/T-lymphoid leukemia with silenced CEBPA and mutations in NOTCH1Bas J Wouters, Meritxell Alberich Jordà, Karen Keeshan, et al.
Nature Communications|July 7, 2024
Epigenetic alterations affecting hematopoietic regulatory networks as drivers of mixed myeloid/lymphoid leukemiaRoger Mulet-Lazaro, Stanley van Herk, Margit Nuetzel, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
The Journal of Molecular Diagnostics : JMD|May 20, 2017
Minimal Residual Disease Monitoring of Acute Myeloid Leukemia by Massively Multiplex Digital PCR in Patients with NPM1 MutationsNuria Mencia-Trinchant, Yang Hu, Maria Antonina Alas, et al.
Cancer Cell|November 14, 2006
Tribbles homolog 2 inactivates C/EBPalpha and causes acute myelogenous leukemiaKaren Keeshan, Yiping He, Bas J Wouters, et al.
Blood|April 8, 2021
Allele-specific expression of GATA2 due to epigenetic dysregulation in CEBPA double-mutant AMLRoger Mulet-Lazaro, Stanley van Herk, Claudia Erpelinck, et al.
Blood|January 27, 2009
Genome-wide epigenetic analysis delineates a biologically distinct immature acute leukemia with myeloid/T-lymphoid featuresMaria E Figueroa, Bas J Wouters, Lucy Skrabanek, et al.
Nature Communications|September 29, 2021
The leukemic oncogene EVI1 hijacks a MYC super-enhancer by CTCF-facilitated loopsSophie Ottema, Roger Mulet-Lazaro, Claudia Erpelinck-Verschueren, et al.
Blood|September 10, 2020
BCL6 maintains survival and self-renewal of primary human acute myeloid leukemia cellsKimihito C Kawabata, Hongliang Zong, Cem Meydan, et al.
Blood|October 8, 2025
MECOM is a master repressor of myeloid differentiation through dose control of CEBPA in acute myeloid leukemiaDorien Pastoors, Marije Havermans, Roger Mulet-Lazaro, et al.
Blood|December 24, 2010
Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entityErdogan Taskesen, Lars Bullinger, Andrea Corbacioglu, et al.
Blood|August 3, 2007
Distinct gene expression profiles of acute myeloid/T-lymphoid leukemia with silenced CEBPA and mutations in NOTCH1Bas J Wouters, Meritxell Alberich Jordà, Karen Keeshan, et al.
Nature Communications|July 7, 2024
Epigenetic alterations affecting hematopoietic regulatory networks as drivers of mixed myeloid/lymphoid leukemiaRoger Mulet-Lazaro, Stanley van Herk, Margit Nuetzel, et al.
Pageof 3